Literature DB >> 7546990

Early reactivation of ischaemia after abrupt discontinuation of heparin in acute myocardial infarction.

G Di Tano1, A Mazzù.   

Abstract

Intravenous heparin after thrombolytic therapy for acute myocardial infarction is an effective, widely used treatment. Six cases of acute myocardial infarction are reported with early disease reactivation following the abrupt discontinuation of heparin infusion three days after alteplase thrombolysis and concomitant aspirin therapy. Immediate reinfusion of heparin resulted in regression of symptomatic ischaemia in all six patients. The activated partial thromboplastin time values, determined four hours before the discontinuation of heparin therapy, were within the therapeutic range in five of the six patients, and no difference was found in the values obtained one hour after the reinfusion of heparin (P = 0.065).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546990      PMCID: PMC483987          DOI: 10.1136/hrt.74.2.131

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

Review 1.  Heparin.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

2.  A standard heparin nomogram for the management of heparin therapy.

Authors:  M K Cruickshank; M N Levine; J Hirsh; R Roberts; M Siguenza
Journal:  Arch Intern Med       Date:  1991-02

3.  On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes.

Authors:  G Melandri; A Branzi; A M Traini; F Semprini; V Cervi; B Magnani
Journal:  Am J Cardiol       Date:  1993-02-15       Impact factor: 2.778

4.  A comparison of heparin strategies after thrombolytic therapy.

Authors:  R C Becker; J M Corrao; S P Ball; J M Gore
Journal:  Am Heart J       Date:  1993-09       Impact factor: 4.749

5.  Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Authors:  J I Weitz; M Hudoba; D Massel; J Maraganore; J Hirsh
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.

Authors:  J Hsia; W P Hamilton; N Kleiman; R Roberts; B R Chaitman; A M Ross
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

7.  Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART Investigators.

Authors:  J Hsia; N Kleiman; F Aguirre; B R Chaitman; R Roberts; A M Ross
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

8.  Reactivation of unstable angina after the discontinuation of heparin.

Authors:  P Théroux; D Waters; J Lam; M Juneau; J McCans
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245

9.  Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.

Authors:  H K Gold; F W Torres; H D Garabedian; W Werner; I K Jang; A Khan; J N Hagstrom; T Yasuda; R C Leinbach; J B Newell
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

10.  Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).

Authors:  J Arnout; M Simoons; D de Bono; H J Rapold; D Collen; M Verstraete
Journal:  J Am Coll Cardiol       Date:  1992-09       Impact factor: 24.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.